A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

A study by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies hold ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

“To test MindGlide’s generalizability across ages 14–64, we employed an external validation set of two progressive MS clinical trials, and a real-world cohort of pediatric relapsing ...

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Immunic’s lead oral small molecule has failed to hit the primary endpoint of a phase 2 trial in patients with progressive multiple sclerosis (PMS), but the New York biotech is pointing to other ...